Journal
Frontiers in Oncology
Publication Date
1-1-2020
Volume
10
First Page
485587
Document Type
Open Access Publication
DOI
10.3389/fonc.2020.485587
Rights and Permissions
Langer CJ, Gajra A, Gridelli C, Konduri K, Morgensztern D, Spigel D, Talbot D, Thomas M, Weiss J, Pilot R, Bhore R, Wolfsteiner M, Ong TJ and Socinski M (2021) nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis. Front. Oncol. 10:485587. doi: 10.3389/fonc.2020.485587 © 2021 Langer, Gajra, Gridelli, Konduri, Morgensztern, Spigel, Talbot, Thomas, Weiss, Pilot, Bhore, Wolfsteiner, Ong and Socinski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Langer, Corey J; Gajra, Ajeet; Gridelli, Cesare; Konduri, Kartik; Morgensztern, Daniel; Spigel, David; Talbot, Denis; Thomas, Michael; Weiss, Jared; Pilot, Richard; Bhore, Rafia; Wolfsteiner, Marianne; Ong, Teng Jin; and Socinski, Mark, "nab-paclitaxel/xarboplatin in vulnerable populations with advanced non-small cell lung cancer: Pooled analysis." Frontiers in Oncology. 10, 485587 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/11273
Supplementary Material
